Mesa Laboratories Ownership
| MLAB Stock | USD 123.50 0.74 0.60% |
Shares in Circulation | First Issued 1987-06-30 | Previous Quarter 5.5 M | Current Value 5.4 M | Avarage Shares Outstanding 3.9 M | Quarterly Volatility 709.7 K |
Mesa |
Mesa Stock Ownership Analysis
About 96.0% of the company shares are owned by institutional investors. The book value of Mesa Laboratories was now reported as 28.57. The company has Price/Earnings (P/E) ratio of 433.94. Mesa Laboratories recorded a loss per share of 46.32. The entity last dividend was issued on the 28th of February 2025. Mesa Laboratories, Inc. develops, manufactures, and sells life sciences tools and quality control products and services in the United States, Europe, the Asia Pacific, and internationally. The company was incorporated in 1982 and is headquartered in Lakewood, Colorado. Mesa Labs operates under Scientific Technical Instruments classification in the United States and is traded on NASDAQ Exchange. It employs 681 people. To find out more about Mesa Laboratories contact the company at 303 987 8000 or learn more at https://www.mesalabs.com.Besides selling stocks to institutional investors, Mesa Laboratories also allocates a substantial amount of its earnings to a pull of share-based compensation to be paid out to its employees, managers, executives, and members of the board of directors. Share-Based compensation (also sometimes called Stock-Based Compensation) is a way of paying different Mesa Laboratories' stakeholders with equity in the business. It is typically used as a motivation factor for employees to contribute beyond their regular compensation (salary and bonus). It is also used as a tool to align Mesa Laboratories' strategic interests with those of the company's shareholders. Shares issued to employees are usually subject to a vesting period before they are earned and sold.
Mesa Laboratories Quarterly Liabilities And Stockholders Equity |
|
Mesa Laboratories Insider Trades History
About 6.0% of Mesa Laboratories are currently held by insiders. Unlike Mesa Laboratories' institutional investors, corporate insiders most likely have a limit on the maximum percentage of share ownership. This is done to align insiders' influence against Mesa Laboratories' private investors even though both sides will benefit from rising prices or experience loss when the share price declines. The good rule to have in mind is that the maximum share ownership percentage of the corporate insiders should not surpass 25%. View all of Mesa Laboratories' insider trades
Mesa Stock Institutional Investors
Have you ever been surprised when a price of an equity instrument such as Mesa Laboratories is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Mesa Laboratories backward and forwards among themselves. Mesa Laboratories' institutional investor refers to the entity that pools money to purchase Mesa Laboratories' securities or originate loans. Institutional investors include commercial and private banks, credit unions, insurance companies, pension funds, hedge funds, endowments, and mutual funds. Operating companies that invest excess capital in these types of assets may also be included in the term and may influence corporate governance by exercising voting rights in their investments.
| Shares | Geode Capital Management, Llc | 2024-12-31 | 124.4 K | Dimensional Fund Advisors, Inc. | 2024-12-31 | 113.8 K | Northern Trust Corp | 2024-12-31 | 93.8 K | Hhg Plc | 2024-12-31 | 86.3 K | Raymond James & Associates | 2024-09-30 | 76.9 K | Kennedy Capital Management Inc | 2024-12-31 | 74.6 K | Bank Of America Corp | 2024-12-31 | 68.5 K | Acadian Asset Management Llc | 2024-12-31 | 68.1 K | Charles Schwab Investment Management Inc | 2024-12-31 | 62.6 K | Blackrock Inc | 2024-12-31 | 844.4 K | Conestoga Capital Advisors, Llc | 2024-12-31 | 573 K |
Mesa Laboratories Insider Trading Activities
Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Mesa Laboratories insiders, such as employees or executives, is commonly permitted as long as it does not rely on Mesa Laboratories' material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases Mesa Laboratories insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
Mesa Laboratories Outstanding Bonds
Mesa Laboratories issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. Mesa Laboratories uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most Mesa bonds can be classified according to their maturity, which is the date when Mesa Laboratories has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.
| Dana 575 percent Corp BondUS235822AB96 | View | |
| MPLX LP 4125 Corp BondUS55336VAK61 | View | |
| MPLX LP 4875 Corp BondUS55336VAJ98 | View | |
| MPLX LP 52 Corp BondUS55336VAL45 | View | |
| Morgan Stanley 3591 Corp BondUS61744YAK47 | View | |
| Morgan Stanley 3971 Corp BondUS61744YAL20 | View | |
| MGM Resorts International Corp BondUS552953CD18 | View | |
| Valero Energy Partners Corp BondUS91914JAA07 | View |
Mesa Laboratories Corporate Filings
8K | 4th of February 2025 Report filed with the SEC to announce major events that shareholders should know about | ViewVerify |
| 28th of January 2025 Other Reports | ViewVerify | |
F4 | 25th of November 2024 The report filed by a party regarding the acquisition or disposition of a company's common stock, as well as derivative securities such as options, warrants, and convertible securities | ViewVerify |
13A | 15th of October 2024 An amended filing to the original Schedule 13G | ViewVerify |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.When determining whether Mesa Laboratories offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Mesa Laboratories' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Mesa Laboratories Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Mesa Laboratories Stock:Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Mesa Laboratories. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in nation. For information on how to trade Mesa Stock refer to our How to Trade Mesa Stock guide.You can also try the Price Exposure Probability module to analyze equity upside and downside potential for a given time horizon across multiple markets.
Is Life Sciences Tools & Services space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Mesa Laboratories. If investors know Mesa will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Mesa Laboratories listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth 3.875 | Dividend Share 0.64 | Earnings Share (46.32) | Revenue Per Share | Quarterly Revenue Growth 0.175 |
The market value of Mesa Laboratories is measured differently than its book value, which is the value of Mesa that is recorded on the company's balance sheet. Investors also form their own opinion of Mesa Laboratories' value that differs from its market value or its book value, called intrinsic value, which is Mesa Laboratories' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Mesa Laboratories' market value can be influenced by many factors that don't directly affect Mesa Laboratories' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Mesa Laboratories' value and its price as these two are different measures arrived at by different means. Investors typically determine if Mesa Laboratories is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Mesa Laboratories' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.